Rabies virus-induced membrane fusion pathway

Journal of Cell Biology

Volumn 150, Issue 3, 2000, Pages 601-611

  Gaudin, Y ^a  

^a CNRS   (France)

Author keywords

Liposome; Lysophosphatidylcholine; Prefusion complex; Rhabdovirus; Viral fusion glycoprotein

Indexed keywords

LIPOSOME; LYSOPHOSPHATIDYLCHOLINE; OLEIC ACID; VIRUS FUSION PROTEIN; VIRUS GLYCOPROTEIN;

ARTICLE; CELL MEMBRANE; MEMBRANE FUSION; MEMBRANE STRUCTURE; MOLECULAR DYNAMICS; PRIORITY JOURNAL; RABIES VIRUS; RHABDOVIRUS; VIRUS ADSORPTION; VIRUS ENVELOPE;

LIPOSOMES; LYSOPHOSPHATIDYLCHOLINES; MEMBRANE FUSION; MODELS, BIOLOGICAL; OLEIC ACID; RABIES VIRUS;

RABIES VIRUS; RHABDOVIRIDAE;

EID: 0034617991     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.150.3.601     Document Type: Article

References (63)

1. Truncation of the COOH-terminal region of the paramyxovirus SV5 fusion protein leads to hemifusion, but not complete fusion
2. Structural basis for paramyxovirus-mediated membrane fusion
3. Dilation of the influenza hemagglutinin pore revealed by the kinetics of individual cell-cell fusion events
4. Translocation of oleic acid across the erythrocyte membrane. Evidence for a fast process
5. Structure of influenza haemagglutinin at the pH of membrane fusion
6. Radiation inactivation analysis of fusion and hemolysis by vesicular stomatitis virus
7. Core structure of gp41 from the HIV envelope glycoprotein
8. Lysolipids reversibly inhibit Ca(2+)-, GTP- and pH-dependent fusion of biological membranes
9. Lipids in biological membrane fusion
10. An early stage of membrane fusion mediated by the low pH conformation of influenza hemagglutinin depends upon membrane lipids
11. The pathway of membrane fusion catalyzed by influenza hemagglutinin: Restriction of lipids, hemifusion, and lipidic fusion pore formation
12. Structural intermediates in influenza haemagglutinin-mediated fusion
13. Gating kinetics of pH-activated membrane fusion of vesicular stomatitis virus with cells: Stopped-flow measurements by dequenching of octadecylrhodamine fluorescence
14. Physical properties of a soluble form of the glycoprotein of vesicular stomatitis virus at neutral and acidic pH
15. Membrane fusion mediated by the influenza virus hemagglutinin requires the concerted action of at least three hemagglutinin trimers
16. Role for adenosine triphosphate in regulating the assembly and transport of vesicular stomatitis virus G protein trimers
17. Photolabeling identifies a putative fusion domain in the envelope glycoprotein of rabies and vesicular stomatitis viruses
18. Retrovirus envelope domain at 1.7 A resolution
19. Vesicular stomatitis virus glycoprorein mutations that affect membrane fusion activity and abolish virus infectivity
20. Mutations at two conserved amino acids in the glycoprotein of vesicular stomatitis virus affect pH-dependent conformational changes and reduce the pH threshold for membrane fusion
21. Trans-bilayer movement of added phosphatidylcholine and lysophosphatidylcholine, species with various acyl chain lengths in plasma membrane of intact human erythrocytes
22. Reversibility in fusion protein conformational changes: The intriguing case of rhabdovirus-induced membrane fusion
23. Reversible conformational changes and fusion activity of rabies virus glycoprotein
24. Rabies virus glycoprotein is a trimer
25. Low-pH conformational changes of rabies virus glycoprotein and their role in membrane fusion
26. Biological function of the low-pH, fusion-inactive conformation of rabies virus glycoprotein (G): G is transported in a fusion-inactive state-like conformation
27. Identification of amino acids controlling the low-pH-induced conformational change of rabies virus glycoprotein
28. Rabies virus-induced membrane fusion
29. How lysophosphatidylcholine inhibits cell-cell fusion mediated by the envelope glycoprotein of human immunodeficiency virus
30. Lipid-anchored influenza hemagglutinin promotes hemifusion, not complete fusion
31. Crystal structure of human T cell leukemia virus type 1 gp21 ectodomain crystallized as a maltose-binding protein chimera reveals structural evolution of retroviral trans-membrane proteins
32. Reversible merger of membranes at the early stage of influenza hemagglutinin-mediated fusion
33. Mutational analysis of the vesicular stomatitis virus glycoprotein G for membrane fusion domains
34. Structure and function of fusion pores in exocytosis and ectoplasmic membrane fusion
35. Stabilization of bilayer structure for unsaturated phosphatidylethanolamines by detergents
36. Membrane fusion mediated by baculovirus gp64 involves assembly of stable gp64 trimers into multiprotein aggregates
37. Influenza hemagglutinin-mediated fusion pores connecting cells to planar membranes: Flickering to final expansion
38. Comparison of transient and successful fusion pores connecting influenza hemagglutinin expressing cells to planar membranes
39. GPI-anchored influenza hemagglutinin induces hemifusion to both red blood cell and planar bilayer membranes
40. Inner, but not outer, membrane leaflets control the transition from glycosylphosphatidyl-inositol-anchored influenza hemagglutinin-induced hemifusion to full fusion
41. The exocytic fusion pore
42. Conformational changes and fusion activity of vesicular stomatitis virus glycoprotein: [(125)I]iodonaphtyl azide photolabeling studies in biological membranes
43. The initial fusion pore induced by baculovirus GP64 is large and forms quickly
44. Activation of vesicular stomatitis virus fusion with cells by pretreatment at low pH
45. Role of viral envelope sialic acid in membrane fusion mediated by the vesicular stomatitis virus envelope glycoproteins
46. A specific point mutant at position 1 of the influenza hemagglutinin fusion peptide displays a hemifusion phenotype
47. A long-lived state for influenza virus-erythrocyte complexes committed to fusion at neutral pH
48. Energetic of intermediates in membrane fusion: Comparison of stalk and inverted micellar intermediate mechanisms
49. Coiled coils in both intracellular vesicle and viral membrane fusion
50. The HA2 subunit of influenza hemagglutinin inserts into the target membrane prior to fusion
51. Use of resonance energy transfer to monitor membrane fusion
52. Membrane flux through the pore formed by a fusogenic viral envelope protein during cell fusion
53. 2-terminal segment during influenza virus-induced membrane fusion
54. Lysophosphatidylcholine reversibly arrests exocytosis and viral fusion at a stage between triggering and membrane merger
55. +-induced insertion of the influenza hemagglutinin HA2 N -terminal segment into the viral membrane
56. Atomic structure of the ectodomain from HIV-1 gp41
57. Crystal structure of the Ebola virus membrane fusion subunit, Gp2, from the envelope glycoprotein ectodomain
58. Electron microscopy of antibody complexes of influenza virus haemagglutinin in the fusion pH conformation
59. Membrane fusion activity, oligomerization, and assembly of the rabies virus glycoprotein
60. Inhibition of membrane fusion by lysophosphatidylcholine
61. Characterization of the putative fusogenic domain in vesicular stomatitis virus glycoprotein G
62. Mechanisms of membrane fusion
63. Restricted movement of lipid and aqueous dyes through pores formed by influenza hemagglutinin during cell fusion